STERIS (STE) Revenue & Revenue Breakdown
STERIS Revenue Highlights
Latest Revenue (Y)
$5.46B
Latest Revenue (Q)
$1.37B
Main Segment (Y)
Product
Main Geography (Y)
UNITED STATES
STERIS Revenue by Period
STERIS Revenue by Year
Date | Revenue | Change |
---|---|---|
2025-03-31 | $5.46B | 6.24% |
2024-03-31 | $5.14B | 13.28% |
2023-03-31 | $4.54B | -1.06% |
2022-03-31 | $4.59B | 47.55% |
2021-03-31 | $3.11B | 2.53% |
2020-03-31 | $3.03B | 8.94% |
2019-03-31 | $2.78B | 6.19% |
2018-03-31 | $2.62B | 0.28% |
2017-03-31 | $2.61B | 16.71% |
2016-03-31 | $2.24B | 21.00% |
2015-03-31 | $1.85B | 14.06% |
2014-03-31 | $1.62B | 8.01% |
2013-03-31 | $1.50B | 7.93% |
2012-03-31 | $1.39B | 15.24% |
2011-03-31 | $1.21B | -4.00% |
2010-03-31 | $1.26B | -3.14% |
2009-03-31 | $1.30B | 2.64% |
2008-03-31 | $1.27B | 5.65% |
2007-03-31 | $1.20B | 3.20% |
2006-03-31 | $1.16B | 3.62% |
2005-03-31 | $1.12B | 8.51% |
2004-03-31 | $1.03B | 6.15% |
2003-03-31 | $972.09M | 12.16% |
2002-03-31 | $866.70M | 8.33% |
2001-03-31 | $800.09M | 5.19% |
2000-03-31 | $760.63M | -4.64% |
1999-03-31 | $797.60M | 10.83% |
1998-03-31 | $719.66M | 22.41% |
1997-03-31 | $587.90M | 9.97% |
1996-03-31 | $534.60M | 731.42% |
1995-03-31 | $64.30M | 40.39% |
1994-03-31 | $45.80M | - |
STERIS generated $5.46B in revenue during NA 2025, up 6.24% compared to the previous quarter, and up 180.13% compared to the same period a year ago.
STERIS Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-12-31 | $1.37B | 3.13% |
2024-09-30 | $1.33B | 3.86% |
2024-06-30 | $1.28B | -9.86% |
2024-03-31 | $1.42B | 1.70% |
2023-12-31 | $1.40B | 3.97% |
2023-09-30 | $1.34B | 4.50% |
2023-06-30 | $1.28B | -7.24% |
2023-03-31 | $1.38B | 13.89% |
2022-12-31 | $1.22B | 1.29% |
2022-09-30 | $1.20B | 3.81% |
2022-06-30 | $1.16B | -4.48% |
2022-03-31 | $1.21B | 0.14% |
2021-12-31 | $1.21B | 1.00% |
2021-09-30 | $1.20B | 23.60% |
2021-06-30 | $968.42M | 10.86% |
2021-03-31 | $873.53M | 7.99% |
2020-12-31 | $808.92M | 6.98% |
2020-09-30 | $756.13M | 13.04% |
2020-06-30 | $668.93M | -18.72% |
2020-03-31 | $822.99M | 6.29% |
2019-12-31 | $774.26M | 5.08% |
2019-09-30 | $736.84M | 5.75% |
2019-06-30 | $696.80M | -9.30% |
2019-03-31 | $768.21M | 10.34% |
2018-12-31 | $696.24M | 2.54% |
2018-09-30 | $678.96M | 6.29% |
2018-06-30 | $638.76M | -10.78% |
2018-03-31 | $715.97M | 8.17% |
2017-12-31 | $661.90M | 4.37% |
2017-09-30 | $634.16M | 4.31% |
2017-06-30 | $607.96M | -10.75% |
2017-03-31 | $681.19M | 5.32% |
2016-12-31 | $646.77M | 0.06% |
2016-09-30 | $646.41M | 1.26% |
2016-06-30 | $638.38M | -7.52% |
2016-03-31 | $690.28M | 56.92% |
2015-12-31 | $439.90M | -10.21% |
2015-09-30 | $489.90M | -20.82% |
2015-06-30 | $618.69M | 23.33% |
2015-03-31 | $501.65M | 21.57% |
2014-12-31 | $412.64M | -10.82% |
2014-09-30 | $462.73M | -2.22% |
2014-06-30 | $473.24M | 1.71% |
2014-03-31 | $465.29M | 26.56% |
2013-12-31 | $367.65M | -4.20% |
2013-09-30 | $383.76M | -5.37% |
2013-06-30 | $405.55M | -5.29% |
2013-03-31 | $428.22M | 27.08% |
2012-12-31 | $336.96M | -5.43% |
2012-09-30 | $356.32M | -6.33% |
2012-06-30 | $380.40M | -2.52% |
2012-03-31 | $390.25M | 22.47% |
2011-12-31 | $318.64M | -7.02% |
2011-09-30 | $342.71M | -3.52% |
2011-06-30 | $355.21M | -5.97% |
2011-03-31 | $377.76M | 99.89% |
2010-12-31 | $188.98M | -39.51% |
2010-09-30 | $312.43M | -4.83% |
2010-06-30 | $328.28M | -1.16% |
2010-03-31 | $332.13M | 17.14% |
2009-12-31 | $283.54M | -9.77% |
2009-09-30 | $314.23M | -4.15% |
2009-06-30 | $327.83M | -4.80% |
2009-03-31 | $344.37M | 10.53% |
2008-12-31 | $311.56M | -3.58% |
2008-09-30 | $323.13M | 1.15% |
2008-06-30 | $319.47M | -14.85% |
2008-03-31 | $375.17M | - |
STERIS generated $1.37B in revenue during Q3 2025, up 3.13% compared to the previous quarter, and up 102.10% compared to the same period a year ago.
STERIS Revenue Breakdown
STERIS Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Mar 25 | Mar 24 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
Product | $2.87B | $2.76B | $2.56B | $1.44B | $1.40B |
Service | $2.59B | $2.37B | $2.03B | $1.66B | $1.63B |
STERIS's latest annual revenue breakdown by segment (product or service), as of Mar 25: Product (52.60%), and Service (47.40%).
Quarterly Revenue by Product
Product/Service | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Product | $801.07M | $718.34M | $695.91M | $656.29M | $483.00M | $804.76M | $762.34M | $713.86M | $679.04M | $666.39M | $637.08M | $684.51M | $697.26M | $685.24M | $489.28M | $427.61M | $375.31M | $339.50M | $301.11M | $393.59M |
Service | $679.47M | $652.23M | $633.00M | $623.21M | $633.15M | $590.89M | $580.02M | $570.68M | $536.95M | $534.12M | $519.41M | $526.18M | $511.71M | $511.75M | $479.14M | $445.92M | $433.61M | $416.63M | $367.82M | $429.40M |
STERIS's latest quarterly revenue breakdown by segment (product or service), as of Mar 25: Product (54.11%), and Service (45.89%).
STERIS Revenue Breakdown by Country
Annual Revenue by Country
Country | Mar 25 | Mar 24 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
Other foreign locations | $1.34B | $1.30B | $1.27B | $808.58M | $755.35M |
IRELAND | $107.32M | $82.69M | $82.01M | $71.91M | $63.82M |
UNITED STATES | $4.01B | $3.75B | $3.23B | $2.23B | $2.21B |
Service | - | - | $2.03B | - | - |
Product | - | - | $2.56B | - | - |
STERIS's latest annual revenue breakdown by geography, as of Mar 25: UNITED STATES (73.41%), Other foreign locations (24.63%), and IRELAND (1.97%).
Quarterly Revenue by Country
Country | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
UNITED STATES | $1.08B | $1.00B | $979.53M | $946.89M | $802.56M | $1.03B | $992.88M | $930.54M | $883.39M | $871.98M | $834.10M | $845.83M | $851.29M | $852.50M | $679.25M | $613.48M | $572.40M | $549.45M | $491.71M | $599.97M |
IRELAND | $38.21M | $24.12M | $22.80M | $22.19M | $22.52M | $19.65M | $20.44M | $20.09M | $17.96M | $17.00M | $18.18M | $19.93M | $20.09M | $20.05M | $21.95M | $20.13M | $20.32M | $17.09M | $14.37M | $17.42M |
Other foreign locations | $363.70M | $343.87M | $326.58M | $310.42M | $291.07M | $350.54M | $329.04M | $333.92M | $314.64M | $311.54M | $304.21M | $344.93M | $337.59M | $324.44M | $267.23M | $239.92M | $216.21M | $189.59M | $162.85M | $205.61M |
STERIS's latest quarterly revenue breakdown by geography, as of Mar 25: UNITED STATES (72.85%), Other foreign locations (24.57%), and IRELAND (2.58%).
STERIS Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
SYK | Stryker | $22.59B | $5.87B |
BSX | Boston Scientific | $16.75B | $4.66B |
SNN | Smith & Nephew | $5.55B | $2.79B |
STE | STERIS | $5.46B | $1.37B |
BRKR | Bruker | $3.37B | $979.60M |
MASI | Masimo | $2.09B | $600.70M |
PODD | Insulet | $2.07B | $597.50M |
ITGR | Integer | $1.72B | $437.39M |
CNMD | CONMED | $1.31B | $321.26M |
LIVN | LivaNova | $1.25B | $321.80M |
PEN | Penumbra | $1.19B | $324.14M |
IRTC | iRhythm | $591.84M | $158.68M |
ZIMV | ZimVie | $449.75M | $111.52M |
GKOS | Glaukos | $383.48M | $106.66M |
ANIK | Anika Therapeutics | $166.66M | $-1.29M |
OFIX | Orthofix Medical | - | $215.66M |